Acute Care Hospitals Moving Towards Ward Realignment Due to Medical Fee Revisions (Part 2) – Nikkei Medical

News Highlights

The medical fee revision scheduled for fiscal year 2026 is expected to accelerate the realignment of wards in acute care hospitals. This second part of the Nikkei Medical article emphasizes the importance of mid-to-long-term management and succession strategies, considering the revision cycle. Benefits of joining a group, such as maintaining facility standards through economies of scale, dispersing the burden of capital investment, and utilizing tax preferential treatment by transitioning to specific medical corporations or social medical corporations, are also mentioned.

Perspective from M&A Medical Editorial Department

This medical fee revision can be described as encouraging acute care hospitals to specialize in more highly professional functions. In particular, the incentives for “ward function conversion” for hospitals with acute care general wards of 200 beds or more can be a direct factor accelerating consideration of business succession or M&A for hospitals finding it difficult to maintain their bed capacity. For example, participation in regional medical collaboration promotion corporations or integration into larger medical corporation groups not only leads to the sharing of management resources but also helps maintain facility standards and disperse the burden of high-cost capital investments. Furthermore, considering tax schemes with a view to transitioning to specific medical corporations or social medical corporations can potentially bring a dual benefit: smooth business succession to the next generation and reduced tax burden in future corporate operations. To respond to changes in the management environment that occur with each revision, the formulation of strategies from a mid-to-long-term perspective is indispensable.

Points Raised by This News

• Incentives for ward function conversion will accelerate M&A and business succession for acute care hospitals struggling to maintain scale.
• Joining a group contributes to management stability by helping to maintain facility standards and disperse capital investment burdens.
• Transitioning to specific medical corporations or social medical corporations is an effective option for balancing the utilization of tax benefits with smooth business succession.
• The urgent task is to formulate mid-to-long-term management and succession strategies, considering the medical fee revision cycle.

Practical Questions Arising from This News

• What specific steps are necessary to utilize the incentives for ward function conversion and advance group formation or corporate transition?
• If a hospital’s acute care ward faces difficulty in maintaining its bed capacity in the future, what alternative solutions can be considered?
• What are the tax advantages and disadvantages of transitioning to a specific medical corporation or social medical corporation, and what are the specific procedures involved?

If You Feel “Should I Consult Too?”

The medical fee revision encouraging “ward function conversion” can significantly impact the future management of your hospital’s acute care wards. Especially if maintaining bed capacity becomes difficult, you may need to consider options such as group formation, corporate integration, or transitioning to a specific medical corporation. By comparing this with your hospital’s management strategy and consulting with experts in M&A and business succession, you can gain a clear path to preparing for future risks and finding the optimal solution.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, supporting the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. [Free consultation here](https://ma-med.net/contact/)